Six other pharmaceutical companies are also waiting for the green light The Directorate General of Drug Administration (DGDA) has granted Beximco, Square, Eskayef and Renata pharmaceutical companies approval for the production and marketing of molnupiravir, the first-ever Covid-19 pill developed by US drugmaker Merck & Co Inc and Ridgeback Biotherapeutics.
NewsSource
https://www.haberahali.com/siyaset/square-and-renata-for-covid-oral-medicine-production-17946.html
A great company to deal with, extremely reliable with a good range of products. Excellent product knowledge, great communication & customer service, fair prices and fast delivery.
Lupin launches Molnupiravir under the brand name Molnulup for the treatment of COVID-19 in adults in India
Bangladesh drug maker Beximco launches worlds first generic of Pfizers COVID antiviral
Dr Reddys introduces anti-COVID drug molnupiravir at Rs 35 per capsule
Square and Renata for Covid oral medicine production
FDA to authorize COVID-19 pills this week: Bloomberg
Molnupiravir Anti Covid 19 drug Molenzavir 200mg and 400mg Premia Biotech Ltd is proud to annouce
Molnupiravir – what you need to know
What to know about molnupiravir, the COVID pill that could be coming to a pharmacy near you
Experimental Antiviral Drug To Become Available in Fight Against COVID
COVID-19: Thousands to take part in trial of game-changing coronavirus pill molnupiravir that can be taken at home
Molnupiravir Anti Covid 19 drug Movinavir 200mg and 400mg
Tremendous pressure, lot of tension, huge cooperation and dedication make this happen to bring Worlds first antiviral drug in Bangladesh